Evidence map›Paper›PMID 40559102›Full record

ReviewJournal of personalized medicine2025

Impact of Pharmacological Treatments on Rheumatoid Arthritis-Associated Diffuse Interstitial Lung Disease: A Systematic Review and Meta-Analysis.

Ariam A Muarif, Rana Algahtani, Lujain H Alghamdi, Sarah S Alghamdi, Lama Al Nemer, Reman Alsaqrah, Yazeed Alsulami, Maha Alsharif, Dana Alznbagi, Lena Aljehani and 5 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of personalized medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ariam A MuarifCollege of Medicine, King Khalid University, Abha 62529, Saudi Arabia.
Rana AlgahtaniCollege of Medicine, King Khalid University, Abha 62529, Saudi Arabia.
Lujain H AlghamdiCollege of Medicine, University of Jeddah, Jeddah 23218, Saudi Arabia.
Sarah S AlghamdiCollege of Medicine, University of Jeddah, Jeddah 23218, Saudi Arabia.ORCID 0009-0006-6874-5772
Lama Al NemerDepartment of Medicine, College of Medicine, Vision Colleges, Riyadh 13226, Saudi Arabia.ORCID 0009-0005-5255-5790
Reman AlsaqrahCollege of Medicine, King Khalid University, Abha 62529, Saudi Arabia.ORCID 0009-0008-5496-5226
Yazeed AlsulamiCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11426, Saudi Arabia.ORCID 0009-0000-4232-1732
Maha AlsharifCollege of Medicine, King Khalid University, Abha 62529, Saudi Arabia.
Dana AlznbagiCollege of Medicine, King Abdulaziz University, Rabigh 25732, Saudi Arabia.
Lena AljehaniCollege of Medicine, University of Jeddah, Jeddah 23218, Saudi Arabia.
Ziyad AlsaeediCollege of Medicine, King Abdulaziz University, Jeddah 80200, Saudi Arabia.
Sultan AlghamdiCollege of Medicine, King Abdulaziz University, Jeddah 80200, Saudi Arabia.
Taif A SayelCollege of Medicine, King Abdulaziz University, Jeddah 80200, Saudi Arabia.
Basma Al GhamdiPulmonology Division, College of Medicine, King Khalid University, Abha 62529, Saudi Arabia.
Ali Al BshabsheAdult Critical Care Division, College of Medicine, King Khalid University, Abha 62529, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

abataceptantifibrotic inhibitorsanti-TNF inhibitorsJAK kinase inhibitorsleflunomidemethotrexateRA-ILDrituximab

Identifiers

PMID40559102
PMCPMC12194092

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.